OSI PHARMACEUTICALS INC (OSIP) has 17 open-market insider trades by 10 insiders since 2006. The most active filer is Robert Alexander Ingram, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Acqusition Inc. Ruby | 10% | — | 2 | $434.9M | 2010-06-07 |
| Robert Alexander Ingram | Dir | — | 4 | $2.4M | 2010-06-08 |
| Michael G. Atieh | Exec. VP & CFO | — | 3 | $846K | 2008-12-13 |
| Joseph Klein III | Dir | — | 2 | $489K | 2010-06-08 |
| G. Morgan Browne | Dir | — | 1 | $377K | 2007-05-22 |
| David W. Niemiec | Dir | — | 1 | $332K | 2010-06-07 |
| Neil Gibson | Sr. VP & CSO | — | 1 | $168K | 2007-12-13 |
| Anker Md Ph.d Dsc Lundemose | EVPCorp. Dev & Strategic Pln | — | 1 | $138K | 2010-06-07 |
| Walter M. Lovenberg Ph.D. | Dir | — | 1 | $71K | 2007-03-01 |
| Angela M. Davies | Sr. VP and CMOOncology | — | 1 | $17K | 2010-06-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Acqusition Inc. Ruby | 10% | Buy | $367.3M | 2010-06-07 |
| Acqusition Inc. Ruby | 10% | Buy | $67.6M | 2010-06-04 |
| Angela M. Davies | Sr. VP and CMO & Oncology | Sell | $17K | 2010-06-01 |
| Colin Goddard | CEO | Sell | $3.6M | 2010-03-01 |
| Barbara A. Wood | Sr. V.P. & General Counsel | Sell | $1.1M | 2010-03-01 |
| Linda E. Amper | Sr. VP & Human Resources | Sell | $876K |
Companies that share insiders with OSIP, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2010-03-01 |
| Anker Md Ph.d Dsc Lundemose | EVP & Corp. Dev & Strategic Pln | Sell | $1.6M | 2010-03-01 |
| Gabriel Leung | EVP & Pres. Pharma. Business | Sell | $2.4M | 2010-03-01 |
| Joseph Klein III | Director | Buy | $34K | 2010-02-01 |
| Joseph Klein III | Director | Buy | $34K | 2010-01-25 |
| Joseph Klein III | Director | Buy | $34K | 2010-01-21 |
| Joseph Klein III | Director | Buy | $32K | 2010-01-11 |
| Joseph Klein III | Director | Buy | $31K | 2010-01-04 |
| John P. White | Director | Sell | $29K | 2009-03-16 |
| John P. White | Director | Sell | $30K | 2009-02-17 |